Gavin Giovannoni, aka Prof G
10 months
We have just published "Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis". It is worth a read if you prescribe or are being treated with an anti-CD20 (ocrelizumab, ofatumumab, ublituximab, rituximab) =>